Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CD81 | P60033 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2064948 | 0.92 | — | — | |
| SCHEMBL3288490 | 0.92 | — | — | |
| SCHEMBL989309 | 0.92 | — | — | |
| SCHEMBL479236 | 0.90 | CYP2C19 (0.31) | — | |
| SCHEMBL2680377 | 0.90 | CYP2C19 (0.31) | — | |
| SCHEMBL3291143 | 0.90 | CYP2C19 (0.31) | — | |
| SCHEMBL3288533 | 0.90 | CYP2C19 (0.31) | — | |
| SCHEMBL3292924 | 0.90 | CYP2C19 (0.31) | — | |
| SCHEMBL6522429 | 0.90 | CYP2C19 (0.31) | — | |
| SCHEMBL2680077 | 0.90 | CYP2C19 (0.31) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3186226-B1 | OXIME SULFONATE DERIVATIVES | BASF SE (DE) | 2020-06-17 | — | — | EP | disclosed |
| US-20190171099-A1 | POLYMERIZABLE COMPOSITION COMPRISING AN OXIME SULFONATE AS THERMAL CURING AGENT | BASF SE (DE) | 2019-06-06 | — | — | US | disclosed |
| US-10241399-B2 | Polymerizable composition comprising an oxime sulfonate as thermal curing agent | BASF SE (DE) | 2019-03-26 | — | — | US | disclosed |
| US-10234761-B2 | Oxime ester photoinitiators | BASF SE (DE) | 2019-03-19 | — | — | US | disclosed |
| EP-2668156-B1 | POLYMERIZABLE COMPOSITION COMPRISING AN OXIME SULFONATE AS THERMAL CURING AGENT | BASF SE (DE) | 2018-10-31 | — | — | EP | disclosed |
| US-20170260132-A1 | OXIME SULFONATE DERIVATIVES | BASF SE (DE) | 2017-09-14 | — | — | US | disclosed |
| EP-3186226-A1 | OXIME SULFONATE DERIVATIVES | BASF SE (DE) | 2017-07-05 | — | — | EP | disclosed |
| US-20160377977-A1 | OXIME ESTER PHOTOINITIATORS | BASF SE (DE) | 2016-12-29 | — | — | US | disclosed |
| EP-3019473-A1 | OXIME ESTER PHOTOINITIATORS | BASF SE (DE) | 2016-05-18 | — | — | EP | disclosed |
| US-9310677-B2 | Polymerizable composition comprising an oxime sulfonate as thermal curing agent | BASF (DE) | 2016-04-12 | — | — | US | disclosed |
| US-20160060214-A1 | POLYMERIZABLE COMPOSITION COMPRISING AN OXIME SULFONATE AS THERMAL CURING AGENT | BASF SE (DE) | 2016-03-03 | — | — | US | disclosed |
| WO-2016030790-A1 | OXIME SULFONATE DERIVATIVES | BASF SE (DE) | 2016-03-03 | — | — | WO | disclosed |
| WO-2015004565-A1 | OXIME ESTER PHOTOINITIATORS | BASF SE (DE) | 2015-01-15 | — | — | WO | disclosed |
| EP-2668156-A1 | POLYMERIZABLE COMPOSITION COMPRISING AN OXIME SULFONATE AS THERMAL CURING AGENT | BASF SE (DE) | 2013-12-04 | — | — | EP | disclosed |
| US-20130308219-A1 | POLYMERIZABLE COMPOSITION COMPRISING AN OXIME SULFONATE AS THERMAL CURING AGENT | BASF SE (DE) | 2013-11-21 | — | — | US | disclosed |
| WO-2012101245-A1 | POLYMERIZABLE COMPOSITION COMPRISING AN OXIME SULFONATE AS THERMAL CURING AGENT | BASF SE (DE) | 2012-08-02 | — | — | WO | disclosed |
| US-7713680-B2 | Radiation sensitive resin composition for forming a protective film, method of forming a protective film from the composition, liquid crystal display device and solid-state image sensing device | JSR CORPORATION (JP) | 2010-05-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10234761-B2 | Oxime ester photoinitiators | C9, C5, CBR3 | CD81 3292/4885 |
| US-20160377977-A1 | OXIME ESTER PHOTOINITIATORS | C5, C9, CBR3 | CD81 3304/4885 |
| US-10241399-B2 | Polymerizable composition comprising an oxime sulfonate as thermal curing agent | SULT1E1, COX6B1, SULT1A1 | CD81 3353/4885 |
| US-20170260132-A1 | OXIME SULFONATE DERIVATIVES | CBR3, CBR1, C1R | CD81 1475/4885 |
| US-20190171099-A1 | POLYMERIZABLE COMPOSITION COMPRISING AN OXIME SULFONATE AS THERMAL CURING AGENT | SULT1E1, COX6B1, SULT1A1 | CD81 3353/4885 |
| US-20160060214-A1 | POLYMERIZABLE COMPOSITION COMPRISING AN OXIME SULFONATE AS THERMAL CURING AGENT | SULT1E1, COX6B1, SULT1A1 | CD81 3353/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.